1. Jennette JC1, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan;65(1):1-11.
2. Greco A, Marinelli C, Fusconi M, Macri GF, Gallo A, De Virgilio A, Zambetti G, de Vincentiis M, Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol. 2016 Jun;29(2):151-9
3. Wright AC, Gibson LE, Davis DM. Cutaneous manifestations of pediatric granulomatosis with polyangiitis: a clinicopathologic and immunopathologic analysis. J Am Acad Dermatol. 2015 May;72(5):859-67
4. Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002 Sep;17(9):754-61. Epub 2002 Aug 8.
5. L.E. Gibson, M.S. Daoud, S.A. Muller, H.O. Perry, Malignant pyodermas revisited Mayo Clin Proc, 72 (8) (1997), pp. 734-736
6. Comfere NI, Macaron NC, Gibson LE. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status. J Cutan Pathol. 2007 Oct;34(10):739-47.
7. Chyu JY, Hagstrom WJ, Soltani K, Faibisoff B, Whitney DH. Wegener's granulomatosis in childhood: cutaneous manifestations as the presenting signs. J Am Acad Dermatol. 1984 Feb;10(2 Pt 2):341-6.
8. Kass A, Fagan JD, Long P. Granulomatosiswith polyangiitis presenting with pyoderma gangrenosum-like ulceration and negative cytoplasmic antineutrophilic cytoplasmic antibodies in a child. Pediatr Dermatol. 2017 Sep;34(5):e231-e234. doi: 10.1111/pde.13230.
9. Moen BH, Nystad TW, Barrett TM, Sandvik LF, A boy in his teens with large ulcerations of the head and neck. Tidsskr Nor Laegeforen. 2019 Apr 8;139(7). doi: 10.4045
10. Frumholtz L, Laurent-Roussel S, Aumaître O, Maurier F, Le Guenno G, Carlotti A, Dallot A, Kemeny JL, Antunes L, Froment N, Fraitag S, London J, Berezne A, Terris B, Le Jeunne C, Mouthon L, Aractingi S, Guillevin L, Dupin N, Terrier B, French Vasculitis Study Group. Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides. Autoimmun Rev. 2017 Nov;16(11):1138-1146. doi: 10.1016/j.autrev.2017.09.009. 14.
11. Cozzani E, Gasparini G, Parodi A. Pyoderma gangrenosum: a systematic review. G Ital Dermatol Venereol. 2014 Oct;149(5):587-600. PMID: 25213386
12. Ahronowitz I, Harp J, Shinkai K, Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012 Jun 1;13(3):191-211
13. Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic criteria of ulcerative pyoderma gangrenosum: A delphicConsensus of international experts. JAMA Dermatol. 2018 Apr 1;154(4):461-466. doi: 10.1001/jamadermatol.2017.5980
14. Powell FC, Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol. 1984 Jun;120(6):757-61
15. Su WP, Davis MD, Weenig RH, Powell FC, Perry HO, Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004 Nov;43(11):790-800
16. George C, Deroide F, Rustin M, Pyoderma gangrenosum - a guide to diagnosis and management, Clin Med (Lond). 2019 May;19(3):224-228.
17. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000 Jan;79(1):37-46.
18. Alavi A, French LE, Davis MD, Brassard A, Kirsner RS., Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2017 Jun;18(3):355-372
19. Greuter T1, Bertoldo F, Rechner R, Straumann A et al Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment. J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):200-206
20. Kechichian E, Haber R, Mourad N, El Khoury R,, Jabbour S,Tomb R, Pediatric pyoderma gangrenosum: a systematic review and update. Int J Dermatol. 2017 May;56(5):486-495
21. Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002 Oct 31;347(18):1412-8
22. Genovese G, Tavecchio S, Berti E, Rongioletti F, Marzano AV. Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review. Rheumatol Int. 2018 Jun;38(6):1139-1151. doi: 10.1007.
23. Donmez S, Pamuk ON, Gedik M, A K R, Bulut G. A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab. Int J Rheum Dis. 2014 May;17(4):471-5. doi: 10.1111/1756-185X.12274.
24. Jariwala MP, Laxer RM .Primary vasculitis in childhood: GPA and MPA in childhood. Front Pediatr 2018 Aug 16;6:226
25. Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM et al, Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have Granulomatosis With Polyangiitis (Wegener's): an arChiVe cohort Study. Arthritis Rheumatol. 2016 Oct;68(10):2514-26.
26. Monari P, Moro R, Motolese A, Misciali C, Baraldi C, Fanti PA, Caccavale S, Puviani M, Olezzi D, Zampieri P, Trevisan G, Nan K, Fiorentini C, Pellacani G, Gualdi G. Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study. Int Wound J. 2018 Dec;15(6):875-879
27. Baltazar D, Haag C, Gupta AS, Marzano AM, Ortega Loayza AG, A comprehensive review of local pharmacologic therapy for pyoderma gangrenosum. Wounds. 2019 Jun;31(6):151-157.
28. Mitali Sen, Sunil Dogra, Manish Rathi, Aman Sharma, Successful treatment of large refractory pyoderma gangrenosum-like presentation of granulomatosis with polyangiitis by Rituximab, Int J Rheum Dis , 2017 Dec;20(12):2200-2202. doi: 10.1111/1756-185X.12882.